High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer-Reply

Tessa G Steenbruggen, Lars C Steggink, Gabe S Sonke^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Access to Document

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer—Reply
Final publisher's version, 42 KB
Request copy

@article{dc28434e2ad540c78e6bc10bb6228579,

title = "High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer-Reply",

author = "Steenbruggen, {Tessa G} and Steggink, {Lars C} and Sonke, {Gabe S}",

year = "2020",

month = aug,

doi = "10.1001/jamaoncol.2020.1649",

language = "English",

volume = "6",

pages = "1299--1300",

journal = "JAMA oncology",

issn = "2374-2437",

publisher = "AMER MEDICAL ASSOC",

number = "8",

}

TY - JOUR

T1 - High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer-Reply

AU - Steenbruggen, Tessa G

AU - Steggink, Lars C

AU - Sonke, Gabe S

PY - 2020/8

Y1 - 2020/8

U2 - 10.1001/jamaoncol.2020.1649

DO - 10.1001/jamaoncol.2020.1649

M3 - Comment/Letter to the editor

C2 - 32496508

SN - 2374-2437

VL - 6

SP - 1299

EP - 1300

JO - JAMA oncology

JF - JAMA oncology

IS - 8

ER -